• Loading stock data...
Est. 2004

Thursday 03/7/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Oak Therapeutics

  • 11:39 AM

    Results of In Vivo Study Signifies Completion of another Critical Milestone in Company’s Phase I of NIAID Contract* to Develop ODS Strip for Anti-Tuberculosis Treatment Option OXNARD, Calif., Oct. 03, 2017, CURR, (GLOBE NEWSWIRE) — Oak Therapeutics, a subsidiary of CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company, has completed an in vivo study that compared the pharmacokinetics of its proprietary 300mg Isoniazid (INH) oral dissolvable strip (ODS) as an anti-tuberculosis (TB) treatment option against an existing

    Read more
  • 2:29 AM

    ELRA NNAN & PSSS More Info @ Web Site: www.OTCMarkets.com Tuesday, October 28th – Follow us on Twitter @PUBLIC_WIRE GNOLF- UP 100% PSSS – UP 89% TPIV – UP 44% SUB PENNY GAINERS – ELRA +337%, NNAN +283%, VTEQ +112%, SVFC +100% and MRIB +71% Stocks that took a tumble today- XTRN down 40% ALCSQ down 33% LEXG, GLFH both down 26%

    Read more
Public Wire Banner